top of page

Pharmaceutical Licensing In/Out Consultancy Service

​IHSN offers comprehensive consultancy services for international pharmaceutical companies seeking to enter the Chinese market. Our expertise includes facilitating licensing agreements for complex generics and APIs, conducting market research, and managing the due diligence process. We specialize in helping Western pharmaceutical companies navigate regulatory requirements and forge strategic partnerships with Chinese OEMs and ODMs, ensuring a smooth market entry.

1 

Key strengths

  • Local entity in Shanghai, ensuring compliance with Chinese regulations.

  • Experienced team with bilingual capabilities, operational since 2018.

  • Proven track record in cross-border healthcare collaboration between the UK and China.

2

Benefits

  • Full-service consultancy, from initial contact to ongoing operational support.

  • Expertise in navigating Chinese regulatory frameworks, minimizing legal and operational risks.

  • Established relationships with leading pharmaceutical manufacturers in China.

3

Key services

  • Market Research: In-depth analysis of target dosages and market positioning.

  • Licensing Management: Negotiation, due diligence, and long-term partnership facilitation.

  • Ongoing Support: Contract management and relationship-building between East and West.

Let's Work Together

To explore partnership opportunities and learn more about how IHSN can support your business, please reach out to Dr. Helen Hu (CEO) at info@ihsn.co.uk. We are committed to providing innovative healthcare solutions that connect the best of Western and Chinese pharmaceutical practices..

bottom of page